| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| Merenskine N-oxide; Merenskine N-oxide | CFN00466 | 96657-95-3 | C18H26ClNO7 = 403.9 | 5mg | QQ客服：3257982914 |
| Merepoxine; Merepoxine | CFN00467 | 115777-94-1 | C18H25NO6 = 351.4 | 5mg | QQ客服：2056216494 |
| Merepoxine N-oxide; Merepoxine N-oxide | CFN00468 | N/A | C18H25NO7 = 367.4 | 5mg | QQ客服：2056216494 |
| 黄樟素 N-氧化物; Riddelline N-oxide | CFN00469 | 75056-11-0 | C18H23NO7 = 365.4 | 5mg | QQ客服：215959384 |
| 凌德草碱N-氧化物; Rinderine N-oxide | CFN00470 | 137821-16-0 | C15H25NO6 = 315.4 | 5mg | QQ客服：1457312923 |
| 歪千里光碱N-氧化物; Sceleratine N-oxide | CFN00471 | 103184-92-5 | C18H27NO8 = 385.4 | 5mg | QQ客服：215959384 |
| 春千里光碱N-氧化物; Senecivernine N-oxide | CFN00472 | 101687-28-9 | C18H25NO6 = 351.4 | 5mg | QQ客服：3257982914 |
| 光萼野百合碱N-氧化物; Usaramine N-oxide | CFN00473 | 117020-54-9 | C18H25NO7 = 367.4 | 5mg | QQ客服：2159513211 |
| 去甲阿托品; Noratropine | CFN00474 | 16839-98-8 | C16H21NO3 = 275.4 | 5mg | QQ客服：215959384 |
| 氢溴酸后马托品; Homatropine hydrobromide | CFN00475 | 51-56-9 | C16H22BrNO3 = 356.3 | 20mg | QQ客服：3257982914 |
| 后马托品; Homatropine | CFN00476 | 87-00-3 | C16H21NO3 = 275.4 | 20mg | QQ客服：2159513211 |
| 6-羟基托品酮; 6-Hydroxytropinone | CFN00477 | 5932-53-6 | C8H13NO2 = 155.2 | 20mg | QQ客服：3257982914 |
| 18-Hydroxyspartioidine; 18-Hydroxyspartioidine | CFN00478 | N/A | C18H23NO6 = 349.4 | 5mg | QQ客服：215959384 |
| 氧化东莨菪碱氢溴酸盐; Scopolamine N-oxide hydrobromide | CFN00479 | 6106-81-6 | C17H22BrNO5 = 400.3 | 20mg | QQ客服：2056216494 |
| Glucohesperin; Glucohesperin | CFN00480 | 33049-17-1 | C14H26KNO10S3 = 503.7 | 5mg | QQ客服：2159513211 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)